Articles from Glancy Prongay Wolke & Rotter LLP

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Prestige Consumer Healthcare (“Prestige Consumer” or the “Company”) (NYSE: PBH) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Alphatec Holdings, Inc. (“Alphatec” or the “Company”) (NASDAQ: ATEC) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Blaize Holdings, Inc. (“Blaize” or the “Company”) (NASDAQ: BZAI) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Hub Group, Inc. (“Hub Group” or the “Company”) (NASDAQ: HUBG) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ: GEHC) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Zoetis Inc. (“Zoetis” or the “Company”) (NYSE: ZTS) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Azenta, Inc. (“Azenta” or the “Company”) (NASDAQ: AZTA) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Phreesia Inc. (“Phreesia” or the “Company”) (NYSE: PHR) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming July 17, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Sportradar Group AG (“Sportradar” or the “Company”) (NASDAQ: SRAD) Class A ordinary shares between November 7, 2024, and April 21, 2026, inclusive (the “Class Period”).

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Commvault Systems Inc. (“Commvault” or the “Company”) (NASDAQ: CVLT) securities between April 29, 2025 and January 26, 2026, inclusive (the “Class Period”). Commvault investors have until July 17, 2026 to file a lead plaintiff motion.

Glancy Prongay Wolke & Rotter LLP (“GPWR”), announces that it has filed a class action lawsuit in the United States District Court for the Central District of California, captioned Elwan v. Veritone, Inc., et al., Case No. 8:26-cv-01275, on behalf of persons and entities that purchased or otherwise acquired Veritone, Inc. (“Veritone” or the “Company”) (NASDAQ: VERI) securities between October 14, 2025 and April 14, 2026, inclusive (the “Class Period”). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”).

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Option Care Health, Inc. (“Option Care Health” or the “Company”) (NASDAQ: OPCH) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Upwork Inc. (“Upwork” or the “Company”) (NASDAQ: UPWK) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Check Point Software Technologies Ltd. (“CHKP” or the “Company”) (NASDAQ: CHKP) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Zillow Group, Inc. (“Zillow” or the “Company”) (NASDAQ: Z, ZG) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of TriSalus Life Sciences Inc. (“TriSalus” or the “Company”) (NASDAQ: TLSI) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of York Space Systems, Inc. (“York Space Systems” or the “Company”) (NYSE: YSS) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Commvault Systems Inc. (“Commvault” or the “Company”) (NASDAQ: CVLT) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Armstrong World Industries, Inc. (“Armstrong World” or the “Company”) (NYSE: AWI) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Sportradar Group AG (“Sportradar” or the “Company”) (NASDAQ: SRAD) Class A ordinary shares between November 7, 2024, and April 21, 2026, inclusive (the “Class Period”). Sportradar investors have until July 17, 2026 to file a lead plaintiff motion.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it is investigating potential claims against the board of directors of Sezzle Inc. (“Sezzle” or the “Company”) (NASDAQ: SEZL) whether the board breached its fiduciary duties to shareholders.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Black Rock Coffee Bar, Inc. (“Black Rock Coffee” or the “Company”) (NASDAQ: BRCB) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Arm Holdings plc (“Arm” or the “Company”) (NASDAQ: ARM) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Prestige Consumer Healthcare (“Prestige Consumer” or the “Company”) (NYSE: PBH) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Zoetis Inc. (“Zoetis” or the “Company”) (NYSE: ZTS) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ: GEHC) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP (GPWR) is proud to announce that partners Rob Prongay, Kara Wolke, and Melissa Wright have been honored with the prestigious California Lawyer of the Year (CLAY) Award by the Daily Journal, California’s leading legal publication. The award, presented on May 6, 2026, recognizes the team’s record-setting achievement in securing a $433.5 million recovery for investors in a securities fraud class action against Alibaba Group Holding Ltd.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Alphatec Holdings, Inc. (“Alphatec” or the “Company”) (NASDAQ: ATEC) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Graphic Packaging Holding Company (“Graphic Packaging” or the “Company”) (NYSE: GPK) securities between February 4, 2025 and February 2, 2026, inclusive (the “Class Period”). Graphic Packaging investors have until July 6, 2026 to file a lead plaintiff motion.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Blaize Holdings, Inc. (“Blaize” or the “Company”) (NASDAQ: BZAI) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Upwork Inc. (“Upwork” or the “Company”) (NASDAQ: UPWK) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Cencora, Inc. (“Cencora” or the “Company”) (NYSE: COR) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Graphic Packaging Holding Company (“Graphic Packaging” or the “Company”) (NYSE: GPK) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming June 23, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Regencell Bioscience Holdings Limited (“Regencell” or the “Company”) (NASDAQ: RGC) securities between October 28, 2024 and October 31, 2025, inclusive (the “Class Period”).

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Option Care Health, Inc. (“Option Care Health” or the “Company”) (NASDAQ: OPCH) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Regencell Bioscience Holdings Limited (“Regencell” or the “Company”) (NASDAQ: RGC) securities between October 28, 2024 and October 31, 2025, inclusive (the “Class Period”). Regencell investors have until June 23, 2026 to file a lead plaintiff motion.

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming June 26, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired SES AI Corporation (“SES AI” or the “Company”) (NYSE: SES) securities between January 29, 2025 and March 4, 2026, inclusive (the “Class Period”).

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming July 6, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired FS KKR Capital Corp. (“FS KKR Capital” or the “Company”) (NYSE: FSK) securities between May 8, 2024 and February 25, 2026, inclusive (the “Class Period”).

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of GeneDx Holdings Corp. (“GeneDx” or the “Company”) (NASDAQ: WGS) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP (“GPWR”), announces that it has filed a class action lawsuit in the United States District Court for the Eastern District of Pennsylvania, captioned Stuart v. FS KKR Capital Corp., et al., Case No. 2:26-cv-02969, on behalf of persons and entities that purchased or otherwise acquired FS KKR Capital Corp. (“FS KKR Capital” or the “Company”) (NYSE: FSK) securities between May 8, 2024 and February 25, 2026, inclusive (the “Class Period”). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”).

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired SES AI Corporation (“SES AI” or the “Company”) (NYSE: SES) securities between January 29, 2025 and March 4, 2026, inclusive (the “Class Period”). SES AI investors have until June 26, 2026 to file a lead plaintiff motion.

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming June 23, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Globant S.A. (“Globant” or the “Company”) (NYSE: GLOB) common stock between February 15, 2024 and August 14, 2025, inclusive (the “Class Period”).

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Check Point Software Technologies Ltd. (“CHKP” or the “Company”) (NASDAQ: CHKP) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming June 22, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired LKQ Corporation (“LKQ” or the “Company”) (NASDAQ: LKQ) common stock between February 27, 2023 and July 23, 2025, inclusive (the “Class Period”).

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Regencell Bioscience Holdings Limited (“Regencell” or the “Company”) (NASDAQ: RGC) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Globant S.A. (“Globant” or the “Company”) (NYSE: GLOB) common stock between February 15, 2024 and August 14, 2025, inclusive (the “Class Period”). Globant investors have until June 23, 2026 to file a lead plaintiff motion.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of SES AI Corporation (“SES AI” or the “Company”) (NYSE: SES) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Globant S.A. (“Globant” or the “Company”) (NYSE: GLOB) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired LKQ Corporation (“LKQ” or the “Company”) (NASDAQ: LKQ) common stock between February 27, 2023 and July 23, 2025, inclusive (the “Class Period”). LKQ investors have until June 22, 2026 to file a lead plaintiff motion.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of LKQ Corporation (“LKQ” or the “Company”) (NASDAQ: LKQ) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Calix, Inc. (“CALX” or the “Company”) (NYSE: CALX) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Sportradar Group AG (“Sportradar” or the “Company”) (NASDAQ: SRAD) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Banco Santander, S.A. (“Banco Santander” or the “Company”) (NYSE: SAN) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of PROCEPT BioRobotics Corporation (“Procept” or the “Company”) (NASDAQ: PRCT) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Barclays PLC (“Barclays” or the “Company”) (NYSE: BCS) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Via Transportation, Inc. (“Via” or the “Company”) (NYSE: VIA) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Distribution Solutions Group, Inc. (“Distribution Solutions” or the “Company”) (NASDAQ: DSGR) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of TruBridge, Inc. (“TruBridge” or the “Company”) (NASDAQ: TBRG) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Arq, Inc. (“Arq” or the “Company”) (NASDAQ: ARQ) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of OneMain Holdings, Inc. (“OneMain” or the “Company”) (NYSE: OMF) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of FS KKR Capital Corp. (“FS KKR” or the “Company”) (NYSE: FSK) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of ADMA Biologics, Inc. (“ADMA” or the “Company”) (NASDAQ: ADMA) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of The Simply Good Foods Company (“Simply Good” or the “Company”) (NASDAQ: SMPL) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of PicS N.V., also known as PicPay Holdings (“PicPay” or the “Company”) (NASDAQ: PICS) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Vertical Aerospace Ltd. (“Vertical Aerospace” or the “Company”) (NYSE: EVTL) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of SunPower Inc. (“SunPower” or the “Company”) (NASDAQ: SPWR) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming June 8, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Stellantis N.V. (“Stellantis” or the “Company”) (NYSE: STLA) common stock between February 26, 2025 and February 5, 2026, inclusive (the “Class Period”).

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Veritone, Inc. (“Veritone” or the “Company”) (NASDAQ: VERI) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP is proud to announce that it has been ranked in Chambers USA California Spotlight Guide 2026. Chambers Spotlight California 2026 highlights 376 ranked firms across 9 regions and 45 distinct practice areas. Covering practice areas from Litigation and Mergers & Acquisitions to Media & Entertainment and Antitrust, the 2026 Guide highlights the standout firms in key practice areas.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of PicS N.V., also known as PicPay Holdings (“PicPay” or the “Company”) (NASDAQ: PICS) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of The Simply Good Foods Company (“Simply Good” or the “Company”) (NASDAQ: SMPL) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming June 8, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Medpace Holdings, Inc. (“Medpace” or the “Company”) (NASDAQ: MEDP) common stock between April 22, 2025 and February 9, 2026, inclusive (the “Class Period”).

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming June 9, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired United Homes Group, Inc. (“United Homes” or the “Company”) (NASDAQ: UHG) securities between May 19, 2025 and February 22, 2026, inclusive (the “Class Period”).